TLR4 and neoplasm: Silencing TLR4/MyD88 signalling in tumour cells not only results in reduced tumour formation but also leads to prolonged survival after subcutaneous tumour injection in mice (Huang et al, 2005; Rakoff-Nahoum and Medzhitov, 2007).